Hubungan Antara Tumor-Infiltrating Lymphocytes (TlLS) dan Grading Histopatologi Pada Triple Negative Breast Cancer (TNBC)

29

DAFTAR PUSTAKA
Abraham L.Kierszenbaum, and Laura L. Tres 2012 Immune-Lymphatic System.
Histology and Cell Biology : An Introduction to Pathology. Published by
Elsevier 346-347
American Cancer Society. What is Breast Cancer? Available online at
http://www.cancer.org/cancer/breastcancer/detailedguide/breast-cancerwhat-is-breast-cancer (Diakses 28 April 2015)
Ankita Singh Rathore. Et. al Prognostic Impact of CD3 Tumor Infiltrating
Lymphocytes in Triple-negative Breast Cancer. Indian Journal of Clinical
Practice, Vol. 24, No. 4, September 2013
Brouckaert O., Wildiers H., Floris G., Neven P. 2012. Update on triple-negative
breast cancer: prognosis and management strategies.

International

Journal of Women‟s Health 2012:4 511–520
Carey Anders, MD and Lisa A. Carey, MD 2008.Understanding and Treating
Triple-Negative Breast Cancer.National Institude of Health;22(11):
1233–1243
Carrie L. Griffiths, MA, PharmD1 2012. Triple Negative Breast Cancer: A Brief

Review of its Characteristics and Treatment Options. Journal
ofPharmacy Practice vol. 25 no. 3 319-323
Coleman, M.P. et al 2008, Cancer survival in five continents: a worldwide
population-based study (CONCORD). Lancet Oncol 2008; 9: 730–56
Cornelia Liedtke,.et. al. 2008. Response to Neoadjuvant Therapy and Long-Term
Survival in Patients With Triple-Negative Breast Cancer. Journal
ofClinical Oncology 26:1275-1281
Dan L. Longo, MD, Anthony S. Fauci, MD, Dennis L. Kasper, MD, Stephen L.
Hauser, MD, J. Larry Jameson, MD, PhD and Joseph Loscalzo, MD,

Universitas Sumatera Utara

30

PhD 2012, „Breast Cancer‟ in Harrison’s Principle of Internal Medicine.
Published by McGraw Hill Medical 754-763
Dr. Shaheenah Dawood 2010 Triple Negative Breast Cancer.Drugs Published by
Adis, 2247-2258
Emad A Rakha et al 2010. Breast cancer prognostic classification in the molecular
era: the role of histological grade. Breast Cancer Research2010,12:207

Gaol H.L dan Briani F. 2014 „Kanker Payudara‟ in „Kapita Selekta Kedokteran‟
GLOBOCAN – BREAST CANCER ESTIMATED INCIDENCE, MORTALITY
AND PREVALENCE WORLDWIDE IN 2012.

Available online at

http://globocan.iarc.fr/old/FactSheets/cancers/breast-new.asp (Diakses 28
April 2015)
Gluz O., Liedtke C., Gottschalk N., PusztaiL., Nitz U., Harbeck N. 2009. Triplenegative breast cancer - current status and future directions. Annals of
Oncology doi:10.1093/annonc/mdp492
K McPherson, C M Steel, J M Dixon 2000. ABC of Breast Diseases – Breast
cancer – epidermiology,risk factors and genetics. British Medical
Journal2000;321:6248
KEMENTERIAN KESEHATAN REPUBLIK INDONESIA (2014) – Hilangkan
mitos

tentang

kanker.


Available

online

at

http://www.depkes.go.id/article/print/201407070001/hilangkan-mitostentang-kanker.html (Diakses 29 April 2015)
Manuaba T.W. (2010) Panduan Pentalaksanaan Kanker Payudara.Panduan
Pentalaksanaan Kanker Payudara in Panduan Penatalaksanaan Kanker
Solid Peraboi 2010 Published by Sagung Seto, 17

Universitas Sumatera Utara

31

Nadine M. Tung, Beth Israel, Eric P. Winer, Dana-Farber 2015.Tumor-Infiltrating
Lymphocytes and Response to Platinum in Triple-Negative Breast
Cancer.Journal of Clinical Oncology Vol 33, No 9 : pp969-971
R. Salgado, et. al. 2014. The evaluation of tumor-infiltrating lymphocytes (TILs)
in breast cancer: recommendation by an International TILs Working

Group 2014. Annals of Oncology 26: 259–271, 2015
Rathore A., Goel M., Makker A., Kumar S., Srivastava AN. 2013.Prognostic
Impact of CD3 Tumor Infiltrating Lymphocytes in Triple-negative Breast
Cancer. Indian Journal of Clinical Practice, Vol. 24, No. 4
William D. Foulkes, M.B., B.S., Ph.D., Ian E. Smith, M.D.,and Jorge S. ReisFilho, M.D., Ph.D. 2010 Triple-Negative Breast Cancer. The New
England Journal of Medicine 2010;363:1938-48.
World Health Organisation (WHO), Breast Cancer : prevention and control –
breast

cancer

burden.

(2013).

Available

online

at


http://www.who.int/cancer/detection/breastcancer/en/index1.html
(Diakses 14 Mei 2015)
World health Organization (WHO), Guidelines for management of breast cancer
(2006)

Available

online

at

http://applications.emro.who.int/dsaf/dsa697.pdf (Diakses 10 Mei 2015)
Zun-Jiang Xie, Li-Min Jia, Ye-Chun He, Jiang-Tao Gao 2006. Morphological
observation of tumor infiltrating immunocytes in human rectal
cancer.World Journal of Gastroenterology 12(11): 1757-1760

Universitas Sumatera Utara